A Robust, Automated Karl Fischer Titration System - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

A Robust, Automated Karl Fischer Titration System
The authors developed a robust, automated system to conduct Karl Fischer moisture assays for lyophilized products.

Pharmaceutical Technology
Volume 33, Issue 11, pp. 52-60


The authors have demonstrated a system that can perform Karl Fischer titration unattended. This instrument is fully validated for use in activities such as lyophilization-cycle development, technology transfer between various manufacturing sites, and manufacturing-discrepancy investigations.

Although the platform upon which this system is based is highly customizable and versatile, the authors decided to sacrifice functionality in favor of robustness. As a result, this instrument requires minimal training for operator proficiency, requires little maintenance, and has seen heavy use. Overall, the instrument it has been a cost-effective tool that saved labor, time, and money.


The authors would like to thank M. Joyce, D. Lawrence, D. Mehrwein, C. Buruel, K. Kifle, A. Gonzales, and P. Hearne for suggestions and help with system validation.

Philippe Lam* is a senior engineer for pharmaceutical process research and development at Genentech, 1 DNA Way, South San Francisco, CA 94080, tel. 650.225.7002, fax 650.225.3616,
. Mike Nariman is a senior systems architect at AB Controls.

*To whom all correspondence should be addressed.

Submitted: Dec. 4, 2008. Accepted: Feb. 19, 2009.

What would you do differently? Submit your comments about this paper in the space below.


1. FDA, Guideline for the Determination of Residual Moisture in Dried Biological Products (Rockville, MD, Jan. 1990).

2. E. Scholz, Karl Fischer Titration, (Springer-Verlag, Berlin, 1984).

3. Mettler–Toledo, "Fundamentals of the Volumetric Karl Fischer Titration," (Mettler–Toledo, Columbus, OH, 1999), p. 42.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here